Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Makers Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Makers Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Makers Lab. - Announcement under Regulation 30 (LODR)-Change in Management

    26 May 2025, 1:23PM Re-appointment of Mr. Vishal Jain as Independent Director for second consecutive term of 5 years
  • Makers Lab. posts Q4 net loss of Rs 1.40 cr

    26 May 2025, 12:43PM The company reported standalone net loss during the quarter stood at Rs 1.40 crore as compared to net loss of Rs 1.56 crore in the previous year quart
  • Makers Lab. - Standalone And Consolidated Q4FY25 Results

    26 May 2025, 12:41PM Standalone and Consolidated Financial Results Q4FY25
  • Makers Lab. - Board Meeting Outcome for Standalone And Consolidated Q4FY25 Results

    26 May 2025, 12:35PM Standalone and Consolidated Q4FY25 Results
  • Makers Lab. - Board Meeting Intimation for Standalone And Consolidated Audited Financial Results For Q4 And FY25

    13 May 2025, 1:24PM Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider
  • Makers Lab. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    9 Apr 2025, 2:50PM As of March 2025, 61.28% is owned by Indian Promoters and 38.73% by Public. <p align=justify> Top five Promoters holding highest number of shares of M
  • Makers Lab. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Apr 2025, 10:57AM Compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31, 2025.

Key fundamentals

Evaluate the intrinsic value of Makers Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 56.3718 65.0288 67.5256 67.4976 63.3164
Liabilities 56.3718 65.0288 67.5256 67.4976 63.3164
Equity 5.9004 5.9004 5.9004 4.917 4.917
Gross Profit -2.2087 -3.7612 -4.1337 3.0475 3.2967
Net Profit 4.6411 -6.9519 -6.3609 0.1718 -1.6166
Cash From Operating Activities -1.5868 -3.0621 -1.423 6.8041 0.6656
NPM(%) 10.8 -14.16 -14.95 0.32 -3.64
Revenue 42.9446 49.0885 42.5467 52.4093 44.4114
Expenses 45.1533 52.8497 46.6804 49.3618 41.1147
ROE(%) 6.54 -9.8 -8.97 0.24 -2.28

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Makers Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 803.05 -0.45 26.62 92.46 301.39 0.62
Lotus Eye Hospital and Institute Ltd 72.28 0.33 205.43 336.90 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 25.50 -1.01 0.00 699.52 -39.50 0.00
Astec Lifesciences Ltd 671.00 -0.89 0.00 317.67 -687.10 0.00

Company Info

YEAR EVENTS 1984 - The Company was Incorporated on 21st July, in the state of Maharashtra and obtained the Certificate of Commencement of Business. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company's object is to manufacture of pharmaceutical formulations and drug intermediaries. 1985 - 70 No. of equity shares subscribed for by the signatories to the Memorandum of Association. 2,99,930 shares then issued at par of which 1,19,930 shares reserved and allotted to the promoters, directors and their friends etc. Remaining 1,80,000 shares issued for public subscription during August 1985. Additional 75,000 shares were allotted to retain oversubscription. 1986 - 3,75,000 No. of equity shares issued at par on rights basis in prop. 1:1. 1989 - Though sales and other income improved to Rs.104.72 lakhs when compared to the previous period, margins continued to remain under pressure due to escalating marketing cost, initial launching expenses of the products and under utilisation of capacities. - 5,00,000 No. of equity shares issued at par on rights basis in prop. 2:3. 1993 - Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April. As per terms of the scheme of amalgamation, the Company allotted 3,02,700 No. of equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL. 2006 - Makers Laboratories Ltd has informed that Mrs Purnima Jain has been appointed as an Additional Director of the Company and designated as the Whole-time Director w.e.f. October 30, 2006. 2010 - Board recommends Dividend of 10%. 2011 - The company has recommended a divided of Re. 1/- per share (10%). 2022 -Company issued rights shares of Rs. 10 in the ratio of 1:5 at a premium of Rs. 140 per share.

YEAR EVENTS 1984 - The Company was Incorporated on 21st July, in the state of Maharashtra and obtained the Certificate of Commencement of Business. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company's object is to manufacture of pharmaceutical formulations and drug intermediaries. 1985 - 70 No. of equity shares subscribed for by the signatories to the Memorandum of Association. 2,99,930 shares then issued at par of which 1,19,930 shares reserved and allotted to the promoters, directors and their friends etc. Remaining 1,80,000 shares issued for public subscription during August 1985. Additional 75,000 shares were allotted to retain oversubscription. 1986 - 3,75,000 No. of equity shares issued at par on rights basis in prop. 1:1. 1989 - Though sales and other income improved to Rs.104.72 lakhs when compared to the previous period, margins continued to remain under pressure due to escalating marketing cost, initial launching expenses of the products and under utilisation of capacities. - 5,00,000 No. of equity shares issued at par on rights basis in prop. 2:3. 1993 - Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April. As per terms of the scheme of amalgamation, the Company allotted 3,02,700 No. of equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL. 2006 - Makers Laboratories Ltd has informed that Mrs Purnima Jain has been appointed as an Additional Director of the Company and designated as the Whole-time Director w.e.f. October 30, 2006. 2010 - Board recommends Dividend of 10%. 2011 - The company has recommended a divided of Re. 1/- per share (10%). 2022 -Company issued rights shares of Rs. 10 in the ratio of 1:5 at a premium of Rs. 140 per share.

Read More

Parent Organisation

Makers Laboratories Ltd.

Founded

09/07/1984

Managing Director

NSE Symbol

FAQ

The current price of Makers Laboratories Ltd is

The 52-week high for Makers Laboratories Ltd is

The market capitalization of Makers Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Makers Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Makers Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Makers Laboratories Ltd shares.

The CEO of Makers Laboratories Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT